ROCKVILLE, Md., April 14 /PRNewswire-FirstCall/ -- InforMedix Holdings, Inc. (OTC Bulletin Board: IFMX), announced that Boothwyn Pharmacy, a visionary pharmacy that sells medication adherence services to senior independent living centers, pharmaceutical companies, managed care organizations, and consumers, will be marketing and selling Med-ePhone and Med-eMonitor products and services to its existing client base. Boothwyn has pioneered the use of pharmacist consultants to provide medication adherence services, diabetes care products, durable medical equipment, and pharmaceutical compounding.
According to Louis Micolucci, President of Boothwyn Pharmacy, "We are excited to add the Med-ePhone and Med-eMonitor products to Boothwyn's ongoing services to improve medication adherence for senior citizens in independent living centers, women with high risk pregnancies monitored through pharmaceutical company programs, and managed care patients. These products from InforMedix will significantly increase the value of the services Boothwyn already offers under existing contracts with our customers, and should allow us to expand our business under new contracts. According to a report from MIT's Sloan School of Management, through improving its customers' medication adherence by 25%, a community pharmacy can increase gross revenues by $1.7 million and gross profits by $400,000 each year. We believe that through our aggressive marketing of InforMedix's products, that Boothwyn will significantly increase its revenues through the improved medication adherence of our customers, which will also further our mission of being at the forefront of improved communications methods to create greater patient outcomes."
Mr. Micolucci went on to state, "We are extremely impressed with the scientific studies validating InforMedix's Med-eXpert System, which links consumers, their loved ones, pharmacists, and care managers to improve medication adherence and health. We intend to distribute Med-ePhone and Med-eMonitor to our existing institutional customers and consumers, and then use these products along with other services we provide to expand our customer base. As a pharmacy that has pioneered methods to improve the care of our consumer customers and our institutional clients, we look forward to advancing this important tradition through our partnership with InforMedix."
Bruce A. Kehr, M.D, chairman and Chief Executive Officer of InforMedix commented, "We are extremely pleased to be partnering with Louis Micolucci and Boothwyn Pharmacy. Louis is a visionary pharmacy entrepreneur who has extended advanced medication adherence services well beyond his consumer base to a number of institutions. We are highly impressed with his business operation and facility, which is beautifully designed, and filled with contrasting symbols of pharmacy practice from past centuries and the high-tech self-care products of today."
About Boothwyn Pharmacy
Established in 1933, Boothwyn Pharmacy Inc., believes that the patient, doctor, pharmacist relationship is the cornerstone of quality healthcare. Services provided include retail prescriptions, customized compounded medications, institutional pharmaceutical needs for its geriatric population, and home health care medical equipment and supplies. Boothwyn Pharmacy, Inc. places itself at the forefront of bringing together innovative practices, state-of-the-art technology and improved communication methods to create greater patient outcomes. Additional services include the provision of pharmaceutical and medical supply services to retail customers as well as those patients with specialized needs in home-care or long-term care settings.
InforMedix, Inc., "The Medication Adherence Solution," is based in Rockville, Maryland. The Company has brought to market its Med-eXpert System for consumer product and disease management markets, which use Med-ePhone and Med-eMonitor units to deliver peace-of-mind, improved independent living, and better health outcomes to patients and their loved ones. The Med-ePhone(TM) System (in testing) prompts, monitors and records medication adherence and health status assessment delivered to patients over mobile phones and landlines using Interactive Voice Response Systems (IVRS), combined with 24/7 monitoring. The Med-eMonitor System ("Medication, Safe and Easy" (TM)) integrates a portable patient-interactive "smart pillbox," hardware, software, and 24/7 monitoring. Both products are designed to enable chronically ill patients and their loved ones, professionals in disease management programs, and medical researchers to efficiently monitor and manage medication and care plan adherence, clinical response, and drug safety. For more information, visit http://www.informedix.com.
Safe Harbor Statement
This press release may contain forward looking statements that involve risks and uncertainties, including statements regarding our business strategy and development plans, expectations regarding increased sales and/or revenues, plans for entering into new businesses, anticipated sources and uses of funds and other statements regarding our plans, objectives, expectations and intentions that are not historical facts. Because these forward-looking statements involve risks and uncertainties, actual results could differ materially from those discussed in this press release. These risks and uncertainties are described in greater detail in the reports that we file with the Securities and Exchange Commission. Our actual results, performance or achievements may vary materially from those expressed or implied in any forward-looking statements. All forward-looking statements reflect our beliefs and expectations as of the date of this press release and should not be relied upon as representing our views as of any subsequent date. While we may elect to update these forward-looking statements publicly at some point in the future, we specifically disclaim any obligation to do so, whether as a result of new information, future events or otherwise.
SOURCE InforMedix Holdings Inc.